超越氟代脱氧葡萄糖:精准医学中的癌症分子影像
本综述聚焦氟代脱氧葡萄糖(FDG)以外的核医学分子影像探针,涵盖生长抑素受体配体、前列腺特异性膜抗原配体、去甲肾上腺素类似物和雌激素类似物等已商用探针,以及成纤维细胞激活蛋白抑制剂、C-X-C趋化因子受体4配体和靶向受体酪氨酸激酶、CD4阳性或CD8阳性肿瘤浸润淋巴细胞、肿瘤相关巨噬细胞及癌症干细胞标志物的单克隆抗体等在研探针,讨论其生物靶点及在各类肿瘤评估中的应用或潜在应用。
要点
- FDG PET广泛用于多种癌症分期和疗效评估,但新核医学探针正越来越多地用于或正在研究用于癌症评估。
- 已商用探针包括神经内分泌肿瘤的生长抑素受体配体、前列腺癌的前列腺特异性膜抗原配体、神经嵴肿瘤的去甲肾上腺素类似物和乳腺癌的雌激素类似物。
- 在研探针包括成纤维细胞激活蛋白抑制剂、C-X-C趋化因子受体4配体和靶向受体酪氨酸激酶等的单克隆抗体。
核心结论
- 这些进展代表分子影像作为精准医学强大工具整合的重要一步,预期对患者管理和结局产生显著影响。
研究设计与样本
- 综述,聚焦FDG以外的核医学分子影像探针及其生物靶点和在各类肿瘤评估中的应用或潜在应用。
主要发现
- 已商用探针包括神经内分泌肿瘤的生长抑素受体配体、前列腺癌的前列腺特异性膜抗原配体、神经母细胞瘤等神经嵴肿瘤的去甲肾上腺素类似物和乳腺癌的雌激素类似物。
- 在研探针包括成纤维细胞激活蛋白抑制剂、C-X-C趋化因子受体4配体以及靶向受体酪氨酸激酶、CD4阳性或CD8阳性肿瘤浸润淋巴细胞、肿瘤相关巨噬细胞和癌症干细胞标志物的单克隆抗体。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging. Nuclear imaging, particularly using fluorine-18-fluorodeoxyglucose positron emission tomography, is widely used in the staging and response assessment of multiple cancer types. However, at this writing, new nuclear medicine probes, especially positron emission tomography tracers, are increasingly used or are being investigated for cancer evaluation. This review focuses on these probes, their biologic targets, and the applications or potential applications for their use in the assessment of various neoplasms, including both probes available for commercial use-such as somatostatin receptor ligands in neuroendocrine tumors, prostate-specific membrane antigen ligands in prostate cancer, norepinephrine analogs in neural crest tumors like neuroblastoma, and estrogen analogs in breast cancer-and others in clinical development, such as fibroblast-activating protein inhibitors, C-X-C chemokine receptor type 4 ligands, and monoclonal antibodies targeting receptor tyrosine kinases, CD4-positive or CD8-positive tumor-infiltrating lymphocytes, tumor-associated macrophages, and cancer stem cell biomarkers. These developments represent a major step toward the integration of molecular imaging as a powerful tool in precision medicine, with an expectedly significant impact on patient management and outcome.
引用
- Juweid ME, Al-Qasem SF, Khuri FR, et al. Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine. CA Cancer J Clin. 2025. PMID: 40183513. doi:10.3322/caac.70007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。